How to Buy Monte Rosa Therapeutics Stock
Monte Rosa Therapeutics Inc
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins.
Monte Rosa Therapeutics stock last closed at $10.57, up 3.12% from the previous day, and has decreased 18.75% in one year. It has overperformed other stocks in the Biotechnology industry by 0.77 percentage points. Monte Rosa Therapeutics stock is currently +9.19% from its 52-week low of $9.68, and -58.98% from its 52-week high of $25.77.
As of Nov 6, 2026, there are 85.31M shares of GLUE outstanding. The market value of GLUE is $901.76M. In the last 24 hours, 1.01M GLUE shares were traded.
How to Buy Monte Rosa Therapeutics Stock
Wondering how to invest in Monte Rosa Therapeutics stock? Here's how.
- Figure out where to buy Monte Rosa Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you figure out where to buy Monte Rosa Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Fund your brokerage account: Select your payment method and add your info.
- Research Monte Rosa Therapeutics stock: The Monte Rosa Therapeutics ticker symbol is GLUE. Is Monte Rosa Therapeutics stock a good investment? Should you buy shares of GLUE? How do GLUE's underlying business fundamentals look? Do top analysts think Monte Rosa Therapeutics is a good buy? Why has GLUE's stock price moved recently? (Hint: Our stock research tools can help you decide if GLUE is a good stock to buy).
- Execute your GLUE purchase: Decide if you will purchase GLUE shares at the current market price or use a limit order to purchase GLUE stock at a given price.
- Keep tabs on your GLUE investment: Create a watchlist to the latest updates on your new investment in Monte Rosa Therapeutics stock.
Step 1: Figure out where to buy Monte Rosa Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy GLUE stock.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've picked your brokerage, it's time to fill out some personal details so you can invest in GLUE today.
How to Start a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Submit your information by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on one of the best stock market apps, you need to deposit funds:
Check out the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Research Monte Rosa Therapeutics stock
Once you have selected the best place to buy Monte Rosa Therapeutics stock, it's crucial to evaluate their stock prior to buying, so you actually wrap your head around the risk and upside.
Monte Rosa Therapeutics stock at a glance
Monte Rosa Therapeutics Due Diligence Checks
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on GLUE's stock page.
What is the fair value of GLUE stock?
Investors use many financial metrics, analyses, models, and charts to gauge GLUE's intrinsic value.
Using relative valuations measures:
- GLUE may be undervalued based on its P/B ratio of 1.85x, relative to Biotechnology industry P/B ratio of 5.19x
You can do more valuation research on GLUE's stock here.
GLUE Financial Summary
Signs that GLUE is financially healthy:
- GLUE has $626.04M in cash and short term investments. This is sufficient to cover its annual cash burn of $32.08M.
- GLUE has cash burn of 32078000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the GLUE balance sheet.
- There are more short-term assets than short-term liabilities on the GLUE balance sheet.
Signs that GLUE is not financially healthy:
- GLUE has a relatively high debt to equity ratio of 0.42.
- Total GLUE debt is higher than 5 years ago, relative to shareholder equity.
- GLUE profit margin has gone down from 13.6% to -560.9% in the past year.
Is it a good time to buy GLUE stock, according to Wall Street analysts?
Out of 6 Equities analysts who give recommendations on GLUE, the consensus analyst rating on Monte Rosa Therapeutics is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent GLUE Analyst Upgrades/Downgrades
Brian Cheng, a top 20% analyst from JP Morgan maintains GLUE with a strong buy rating and lowers their GLUE price target from $31.00 to $27.00, on Aug 7, 2026.
You can dig deeper into what analysts are projecting on the Monte Rosa Therapeutics stock forecast page.
GLUE Technical Indicators
Is GLUE Growing Revenue?
Last year, GLUE revenue was $28.73M. Over the past 2 year, GLUE's revenue has increased by 123.34% per year. This was faster than the Biotechnology industry average of 26.22%.
Learn more about GLUE's earnings and revenue performance here.
Are GLUE insiders buying or selling the stock?
In the past year, executives and large shareholders at GLUE have sold more shares than they have bought.
Matthew Bowen, PAO of GLUE, was the latest GLUE insider to sell. They sold $137.28 worth of GLUE shares on Oct 5, 2026.
Research more about who owns GLUE shares here.
Can I rely on GLUE as an income stream?
No, Monte Rosa Therapeutics doesn't provide an income stream by paying out dividends.
What do other investors have to say about GLUE?
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your GLUE purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, place a limit order.
Hit the Open Trade button and your broker will execute the order.
If you want additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your GLUE investment
Now that you own some GLUE stock, you'll want to stay up-to-date on your investment.
Start a watchlist to get notified of important updates regarding your GLUE stock.
GLUE Feed
How to Buy Stock in Monte Rosa Therapeutics
To reiterate, here are the 6 steps for buying Monte Rosa Therapeutics stock:
- Figure out where to buy Monte Rosa Therapeutics stock
- Open your brokerage account
- Fund your brokerage account
- Research Monte Rosa Therapeutics stock
- Execute your GLUE purchase
- Keep tabs on your GLUE investment
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to track your investment in Monte Rosa Therapeutics, create a watchlist today.
More "How To" Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.